“Deucravacitinib in Plaque Psoriasis: Immune Response to and Safety of Pneumococcus and Tetanus Toxoid Vaccines in the POETYK LTE Trial” (2025) SKIN The Journal of Cutaneous Medicine, 9(2), p. s534. doi:10.25251/skin.10.supp.534.